Literature DB >> 20040311

Autophagy in skeletal muscle: implications for Pompe disease.

L Shea1, N Raben.   

Abstract

Pompe disease is caused by an inherited deficiency of acid a-glucosidase (GAA), a lysosomal enzyme that catalyzes the breakdown of glycogen to glucose. In the absence of GAA, enlarged, glycogen-laden lysosomes accumulate in multiple tissues, although the major clinical manifestations are seen in cardiac and skeletal muscle. For many years, it was believed that the rupture of glycogen-filled lysosomes was the major cause of the profound muscle damage observed in patients with Pompe disease. Here, we present evidence that a failure of productive autophagy in muscle tissue contributes strongly to disease pathology in both patients with Pompe disease and GAA-knockout mice. In the GAA-knockout mouse model, progressive accumulation of autophagic vesicles is restricted to Type II-rich muscle fibers. Not only does this build-up of autophagosomes disrupt the contractile apparatus in the muscle fibers, it also interferes with enzyme replacement therapy by acting as a sink for the recombinant enzyme and preventing its efficient delivery to the lysosomes. Our data indicate that a re-examination of the presumed pathological mechanism in Pompe disease is necessary, and suggest that successful treatment of patients with Pompe disease will require consideration of the dramatic failure of autophagy that occurs in this disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20040311      PMCID: PMC2948975          DOI: 10.5414/cpp47042

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther        ISSN: 0946-1965            Impact factor:   1.366


  23 in total

1.  LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing.

Authors:  Y Kabeya; N Mizushima; T Ueno; A Yamamoto; T Kirisako; T Noda; E Kominami; Y Ohsumi; T Yoshimori
Journal:  EMBO J       Date:  2000-11-01       Impact factor: 11.598

Review 2.  Mannose 6-phosphate receptors: new twists in the tale.

Authors:  Pradipta Ghosh; Nancy M Dahms; Stuart Kornfeld
Journal:  Nat Rev Mol Cell Biol       Date:  2003-03       Impact factor: 94.444

3.  Autophagy and lysosomes in Pompe disease.

Authors:  Tokiko Fukuda; Ashley Roberts; Meghan Ahearn; Kristien Zaal; Evelyn Ralston; Paul H Plotz; Nina Raben
Journal:  Autophagy       Date:  2006-10-05       Impact factor: 16.016

4.  Structural and functional changes of lysosomal acid alpha-glucosidase during intracellular transport and maturation.

Authors:  H A Wisselaar; M A Kroos; M M Hermans; J van Beeumen; A J Reuser
Journal:  J Biol Chem       Date:  1993-01-25       Impact factor: 5.157

5.  Recombinant human alpha-glucosidase from rabbit milk in Pompe patients.

Authors:  H Van den Hout; A J Reuser; A G Vulto; M C Loonen; A Cromme-Dijkhuis; A T Van der Ploeg
Journal:  Lancet       Date:  2000-07-29       Impact factor: 79.321

6.  Autophagy and mistargeting of therapeutic enzyme in skeletal muscle in Pompe disease.

Authors:  Tokiko Fukuda; Meghan Ahearn; Ashley Roberts; Robert J Mattaliano; Kristien Zaal; Evelyn Ralston; Paul H Plotz; Nina Raben
Journal:  Mol Ther       Date:  2006-09-27       Impact factor: 11.454

7.  Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease.

Authors:  P S Kishnani; D Corzo; M Nicolino; B Byrne; H Mandel; W L Hwu; N Leslie; J Levine; C Spencer; M McDonald; J Li; J Dumontier; M Halberthal; Y H Chien; R Hopkin; S Vijayaraghavan; D Gruskin; D Bartholomew; A van der Ploeg; J P Clancy; R Parini; G Morin; M Beck; G S De la Gastine; M Jokic; B Thurberg; S Richards; D Bali; M Davison; M A Worden; Y T Chen; J E Wraith
Journal:  Neurology       Date:  2006-12-06       Impact factor: 9.910

8.  Deconstructing Pompe disease by analyzing single muscle fibers: to see a world in a grain of sand...

Authors:  Nina Raben; Shoichi Takikita; Maria G Pittis; Bruno Bembi; Suely K N Marie; Ashley Roberts; Laura Page; Priya S Kishnani; Benedikt G H Schoser; Yin-Hsiu Chien; Evelyn Ralston; Kanneboyina Nagaraju; Paul H Plotz
Journal:  Autophagy       Date:  2007-06-15       Impact factor: 16.016

9.  Morphological changes in muscle tissue of patients with infantile Pompe's disease receiving enzyme replacement therapy.

Authors:  Léon P F Winkel; Joep H J Kamphoven; Hannerieke J M P van den Hout; Lies A Severijnen; Pieter A van Doorn; Arnold J J Reuser; Ans T van der Ploeg
Journal:  Muscle Nerve       Date:  2003-06       Impact factor: 3.217

10.  Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I/II clinical trial.

Authors:  A Amalfitano; A R Bengur; R P Morse; J M Majure; L E Case; D L Veerling; J Mackey; P Kishnani; W Smith; A McVie-Wylie; J A Sullivan; G E Hoganson; J A Phillips; G B Schaefer; J Charrow; R E Ware; E H Bossen; Y T Chen
Journal:  Genet Med       Date:  2001 Mar-Apr       Impact factor: 8.822

View more
  36 in total

Review 1.  Autophagy at the crossroads of catabolism and anabolism.

Authors:  Jasvinder Kaur; Jayanta Debnath
Journal:  Nat Rev Mol Cell Biol       Date:  2015-07-15       Impact factor: 94.444

Review 2.  Pros and cons of different ways to address dysfunctional autophagy in Pompe disease.

Authors:  Jeong-A Lim; Naresh Kumar Meena; Nina Raben
Journal:  Ann Transl Med       Date:  2019-07

3.  Therapeutic Benefit of Autophagy Modulation in Pompe Disease.

Authors:  Jeong-A Lim; Baodong Sun; Rosa Puertollano; Nina Raben
Journal:  Mol Ther       Date:  2018-05-03       Impact factor: 11.454

4.  Novel degenerative and developmental defects in a zebrafish model of mucolipidosis type IV.

Authors:  Huiqing Li; Wuhong Pei; Sivia Vergarajauregui; Patricia M Zerfas; Nina Raben; Shawn M Burgess; Rosa Puertollano
Journal:  Hum Mol Genet       Date:  2017-07-15       Impact factor: 6.150

5.  Muscle fiber-type distribution, fiber-type-specific damage, and the Pompe disease phenotype.

Authors:  L E M van den Berg; M R Drost; G Schaart; J de Laat; P A van Doorn; A T van der Ploeg; A J J Reuser
Journal:  J Inherit Metab Dis       Date:  2012-10-11       Impact factor: 4.982

6.  Pharmacological enhancement of α-glucosidase by the allosteric chaperone N-acetylcysteine.

Authors:  Caterina Porto; Maria C Ferrara; Massimiliano Meli; Emma Acampora; Valeria Avolio; Margherita Rosa; Beatrice Cobucci-Ponzano; Giorgio Colombo; Marco Moracci; Generoso Andria; Giancarlo Parenti
Journal:  Mol Ther       Date:  2012-09-18       Impact factor: 11.454

7.  Lipid-enriched diet rescues lethality and slows down progression in a murine model of VCP-associated disease.

Authors:  Katrina J Llewellyn; Angèle Nalbandian; Kwang-Mook Jung; Christopher Nguyen; Agnesa Avanesian; Tahseen Mozaffar; Daniele Piomelli; Virginia E Kimonis
Journal:  Hum Mol Genet       Date:  2013-10-24       Impact factor: 6.150

8.  Pompe disease results in a Golgi-based glycosylation deficit in human induced pluripotent stem cell-derived cardiomyocytes.

Authors:  Kunil K Raval; Ran Tao; Brent E White; Willem J De Lange; Chad H Koonce; Junying Yu; Priya S Kishnani; James A Thomson; Deane F Mosher; John C Ralphe; Timothy J Kamp
Journal:  J Biol Chem       Date:  2014-12-08       Impact factor: 5.157

9.  Laforin, the most common protein mutated in Lafora disease, regulates autophagy.

Authors:  Carmen Aguado; Sovan Sarkar; Viktor I Korolchuk; Olga Criado; Santiago Vernia; Patricia Boya; Pascual Sanz; Santiago Rodríguez de Córdoba; Erwin Knecht; David C Rubinsztein
Journal:  Hum Mol Genet       Date:  2010-05-07       Impact factor: 6.150

10.  Lipin-1 regulates Bnip3-mediated mitophagy in glycolytic muscle.

Authors:  Abdullah A Alshudukhi; Jing Zhu; Dengtong Huang; Abdulrahman Jama; Jeffrey D Smith; Qing Jun Wang; Karyn A Esser; Hongmei Ren
Journal:  FASEB J       Date:  2018-06-25       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.